Last updated: March 10, 2020
|Product name||T2 Mapping|
|Disease targeted||Solid tumors, Prostate cancer, Rectal Cancer, Breast Cancer|
|Key-features||T2 values, T2 Histogram|
|Suggested use||During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand) (Need to draw ROI)|
|Population||Assessment and monitoring of solid tumors and cartilage changes|
|Input||MRI T2 Multi-echo|
|Output||One-page structured report: ROI, T2 map, T2 histogram, T2 fitting, statistics summary|
|Integration||Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased|
|Deployment||Locally on dedicated hardware, Locally virtualized (virtual machine, docker), Cloud-based, Hybrid solution|
|Trigger for analysis||Automatically after drawing ROI|
|Processing time||1 - 10 minutes|
|CE||Certified, Class IIa|
|FDA||No or not yet|
|On market since||01-2019|
|Countries present (clinical, non-research use)||2|
|Paying clinical customers (institutes)||5+|
|Research/test users (institutes)|
|Based on||Number of installations, Number of analyses|
|Peer reviewed papers on performance|
|Non-peer reviewed papers on performance|
|Other relevant papers||Crema MD et al. Articular cartilage in the knee: current MR imaging techniques and applications in clinical practice and research. RadioGraphics 2011;31:37-61.
Sanz-Requena R et al. Modification of longitudinal relaxation time (T1) as a biomarker of patellar cartilage degeneration. Radiologia 2010;52:221-227.
Sanz R et al. MR pharmacokinetic modeling of the patellar cartilage differentiates normal from pathological conditions. J Magn Reson Imaging 2008;27:171-177.